ALB and Alzheimer disease: In agreement, results of the current cohort study suggest that in W with AD a reduction of plasma levels of albumin, in combination with the chronic poli-pharmacological treatment adopted (that additionally reduces antioxidant binding capacity of albumin), significantly affected BM (Fig 5).